Business ❯ Pharmaceutical Industry ❯ Drug Development

Clinical Research

Market Competition Partnerships Regulatory Affairs Sanofi Novo Nordisk Market Withdrawal Market Approval UCB SA MindMed Stock Performance Veterinary Drugs Market Competitiveness Bayer Market Impact AstraZeneca Global Trials Eli Lilly and Co Phase 3 Trials Investment Risks Moderna Drug Safety Phase III Trials Market Applications Lykos Therapeutics Workforce Management Market Analysis

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

Bayer says it will seek regulatory approval following the positive OCEANIC-STROKE results.

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Junshi’s Subcutaneous Toripalimab Matches IV in Phase 3 NSCLC Trial as Company Prepares NDA

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

AstraZeneca’s Fasenra Misses Primary Endpoint in COPD Phase III Trial